Delivery Order SPE2DB22D2108-SPE2DB25FU5WL
- Not listed
- The Defense Logistics Agency awarded a $1,593.58 delivery order to AmerisourceBergen Drug Corp for VEOZAH 45 mg tablets (30-count) under a firm fixed-price contract with an ultimate completion date of July 24, 2025. This non-competitive, non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,254.01 for Veozah 45 mg tablets (30-count units) on September 10, 2025, with completion scheduled for September 11, 2025. This firm fixed-price contract represents a non-competitive set-aside procurement for pharmaceutical supply to support federal medical needs. The award was fulfilled by AmerisourceBergen's Corporate Office division, with performance conducted at the company's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Veozah 45 mg tablets in quantities of 30 units. This competitive award, with a ceiling value of $6,521.93, represents a firm fixed-price delivery order with an ultimate completion date of September 4, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,976.56 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count) on May 30, 2025, with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $2,575.22 to AmerisourceBergen Drug Corp for VEOZAH 45 mg tablets (30-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Veozah 45 mg tablets (30-count units) at a ceiling value of $1,582.61. This competitive award, which carries no set-aside designation, represents a firm fixed price delivery order and is expected to be completed by September 11, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,983.06, is a delivery order that provides Firm Fixed Price pharmaceutical products, specifically VEOZAH 45 MG TABLET 30S. The contract has an ultimate completion date of March 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of VEOZAH 45 MG TABLET 30S. The $3,325.72 contract has an ultimate completion date of July 17, 2025. AmerisourceBergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and serves as a critical vendor for federal medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of the pharmaceutical product "VEOZAH 45 MG TABLET 30S" at a ceiling value of $4,719.41. The award has a firm fixed price and an ultimate completion date of August 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through...
- The Defense Logistics Agency awarded a delivery order valued at $3,715.38 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count) on September 8, 2025, with completion targeted for September 9, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract with...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU5WLDelivery Order
AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on September 17, 2025, for VEOZAH 45 mg tablets (30-count units) with a ceiling value of $2,227.38 under a firm fixed-price contract structure. This delivery order represents a competitive award with no set-aside designation, issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform this contract at its Corporate Office location in Conshohocken, PA 19428, with an ultimate completion date of September 18, 2025. AmerisourceBergen Drug Corp serves as a critical vendor within the DLA's Medical Supply Chain, providing a comprehensive portfolio of pharmaceutical products and medical supplies to support military healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract awards demonstrate its capability to fulfill diverse medical procurement requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This particular delivery order for VEOZAH—a medication used in select therapeutic applications—exemplifies the company's role in supplying pharmaceutical commodities essential to military and federal healthcare operations. The non-set-aside, competitively awarded nature of this contract reflects AmerisourceBergen's established position as a qualified federal pharmaceutical supplier capable of meeting stringent procurement standards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/17/25 |